SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 222 filers reported holding SEATTLE GENETICS INC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $332,000 | -40.8% | 8,600 | -25.9% | 0.31% | -10.9% |
| Q2 2015 | $561,000 | +58.5% | 11,600 | +16.0% | 0.35% | +47.9% |
| Q1 2015 | $354,000 | +10.3% | 10,000 | 0.0% | 0.24% | +36.4% |
| Q4 2014 | $321,000 | -13.7% | 10,000 | 0.0% | 0.17% | -34.2% |
| Q3 2014 | $372,000 | -2.9% | 10,000 | 0.0% | 0.26% | +10.5% |
| Q2 2014 | $383,000 | -51.9% | 10,000 | -42.9% | 0.24% | -44.7% |
| Q1 2014 | $797,000 | +33.3% | 17,500 | +16.7% | 0.43% | +48.8% |
| Q4 2013 | $598,000 | -9.0% | 15,000 | 0.0% | 0.29% | -27.9% |
| Q3 2013 | $657,000 | +108.6% | 15,000 | +50.0% | 0.40% | +79.0% |
| Q2 2013 | $315,000 | – | 10,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |